Antiviral Combination Therapy With Low-Dose Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Virus Recurrence in Liver Transplant Recipients: A Single-Center Experience

AKÇAM, ATILGAN; ULKU, ABDULLAH; RENCÜZOĞULLARI, AHMET; ERAY, İSMAİL; Okoh, A.; KURAN, SEDEF; DALCI, KUBİLAY; YALAV, ORÇUN; PARSAK, CEM; SAKMAN, GÜRHAN; DEMIRYUREK, H.

doi:10.1016/j.transproceed.2015.04.018

Antiviral Combination Therapy With Low-Dose Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Virus Recurrence in Liver Transplant Recipients: A Single-Center Experience

Atıf İçin Kopyala

AKÇAM A. T., ULKU A., RENCÜZOĞULLARI A., ERAY İ. C., Okoh A., KURAN S., ...Daha Fazla

TRANSPLANTATION PROCEEDINGS, cilt.47, sa.5, ss.1445-1449, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 47 Sayı: 5
Basım Tarihi: 2015
Doi Numarası: 10.1016/j.transproceed.2015.04.018
Dergi Adı: TRANSPLANTATION PROCEEDINGS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1445-1449
Çukurova Üniversitesi Adresli: Evet

Özet

Objectives. This study presents the overall long-term hepatitis B virus (HBV) recurrence rate with possible associated factors after hepatitis B immunoglobulin (HBIG) was given in combination with 4 different antiviral (lamivudine, adefovir, entecavir, and tenofovir) drugs.